MedTrace Logo

Combined Spinal Epidural Anesthesia in Obese Patients Undergoing Cesarean Surgery

NCT04612998 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-11-03

No results posted yet for this study

Summary

This study investigated the maternal and fetal effects during performance of CSEA in the left lateral decubitus and sitting positions in obese pregnant women undergoing elective cesarean section.

Conditions

  • Obesity
  • Pregnancy Related
  • Cesarean Section Complications
  • Spinal Anaesthetic Poisoning of Undetermined Intent
  • Hypotension

Interventions

OTHER

left lateral decubitus position

Comparator group consisted of patients performing CSEA in the left lateral decubitus position.

OTHER

sitting position

Active control group consisted of patients performing CSEA in the sitting position.

DRUG

The use of intravenous ephedrine.

Intravenous ephedrine (6 mg) was used to treat hypotension (a 30% decrease in systolic blood pressure compared to preoperative values) during surgery.

DRUG

The use of intravenous atropine.

Intravenous atropine (1 mg) was given in case of bradycardia (the heart rate \< 45 beats/minute) during surgery.

DRUG

The use of intravenous metoclopramide

When nausea and vomiting were observed, intravenous metoclopramide (10 mg) was administered.

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Principal Investigators

  • Mehmet AKSOY · Faculty of Medicine, Ataturk University, Erzurum, Turkey

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2018-03-01
Completion
2018-04-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04612998 on ClinicalTrials.gov